Skip to content

Effect of Prewarming on Microcirculatory Response

Effect of Prewarming on Microcirculatory Response

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02186210
Enrollment
40
Registered
2014-07-10
Start date
2014-07-31
Completion date
2015-05-31
Last updated
2019-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Bypass Graft Triple Vessel

Keywords

microcirculation, off-pump coronary artery bypass surgery, tissue oxygen saturation, vascular occlusion test, recovery slope

Brief summary

Intraoperative hypothermia may affect tissue microcirculation and can induce myocardial injury, wound infection, and coagulopathy. During off-pump coronary artery bypass surgery without cardiopulmonary bypass or induced hypothermia, maintenance of normothermia is important for clinical outcome. The investigators hypothesized that prewarming during induction of general anesthesia would reduce drop of body temperature and change of peripheral microcirculation.

Detailed description

Microcirculatory parameters can be obtained from vascular occlusion test. Among those parameters, recovery slope during vascular occlusion test is known to reflect recruitment of microvasculature in response to hypoxic or ischemic insult. In this study, we will compare the recovery slope during vascular occlusion test between prewarming treatment group and control group.

Interventions

recovery slope StO2

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* off-pump coronary artery bypass surgery

Exclusion criteria

* refuse to enroll * cannot undergo vascular occlusion test: anatomical abnormality of both arms, severe peripheral vascular disease, presence of A-V fistula * preoperative left ventricular ejection fraction \< 35% * preoperative continuous infusion of vasopressor or inotropes * pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Recovery Slope3 hours after induction of anesthesiaWe will compare recovery slope assessed 3 hours after induction of anesthesia to evaluate the effect of prewarming during induction of anesthesia on microcirculation.

Secondary

MeasureTime frame
Tissue Oxygen SaturationDuring the surgery, an average of 4 hours

Countries

South Korea

Participant flow

Participants by arm

ArmCount
Prewarming
prewarming during induction of anesthesia prewarming: recovery slope StO2
20
Control
no prewarming during induction of anesthesia
20
Total40

Baseline characteristics

CharacteristicControlTotalPrewarming
Age, Continuous66 years
STANDARD_DEVIATION 8
65 years
STANDARD_DEVIATION 8
63 years
STANDARD_DEVIATION 9
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
Korea, Republic of
20 participants40 participants20 participants
Sex: Female, Male
Female
4 Participants10 Participants6 Participants
Sex: Female, Male
Male
16 Participants30 Participants14 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 200 / 20
other
Total, other adverse events
0 / 200 / 20
serious
Total, serious adverse events
0 / 200 / 20

Outcome results

Primary

Recovery Slope

We will compare recovery slope assessed 3 hours after induction of anesthesia to evaluate the effect of prewarming during induction of anesthesia on microcirculation.

Time frame: 3 hours after induction of anesthesia

ArmMeasureValue (MEAN)Dispersion
PrewarmingRecovery Slope2.8 % / sec (recovery slope unit)Standard Deviation 1
ControlRecovery Slope3.1 % / sec (recovery slope unit)Standard Deviation 1.5
Secondary

Tissue Oxygen Saturation

Time frame: During the surgery, an average of 4 hours

ArmMeasureValue (MEAN)Dispersion
PrewarmingTissue Oxygen Saturation76 % (percent of tissue saturation)Standard Deviation 10
ControlTissue Oxygen Saturation79 % (percent of tissue saturation)Standard Deviation 7

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026